NKT cells activate the release of IFN-γ in HCC mainly through exogenous glycolipids (a-GalCer) to exert anti-tumor effects, and IL-4 can also activate N KT cells [34, 52]. This evidence concerns the gene IL4 and hepatocellular carcinoma.